Factor XI deficiency.
D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001779:Blood Coagulation Factors / Q000502:physiology; D005167:Factor VII / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015942:Factor VIIa; D005173:Factor XI Deficiency / Q000150:complications / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D005260:Female; D005342:Fibrinolysis / Q000502:physiology; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy; D006470:Hemorrhage / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014842:von Willebrand Diseases / Q000150:complications / Q000188:drug therapy
D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa